In sickle cell disease: September 2007
## Core Concept
Sickle cell disease is a genetic disorder characterized by the production of abnormal **hemoglobin** (HbS), leading to sickling of red blood cells under certain conditions. This results in vaso-occlusive crises and hemolytic anemia. The disease is caused by a point mutation in the **HBB** gene.
## Why the Correct Answer is Right
The correct answer, , involves understanding the specific mutation leading to sickle cell disease. The mutation results in **glutamic acid** being replaced by **valine** at position 6 of the beta-globin chain of hemoglobin, creating **HbS**. This change causes hemoglobin to polymerize under low oxygen conditions, leading to the sickling of red blood cells.
## Why Each Wrong Option is Incorrect
* **Option A:** This option is incorrect because it does not accurately describe the mutation or the resulting abnormality in sickle cell disease.
* **Option B:** This option is incorrect as it also fails to accurately represent the genetic or molecular basis of sickle cell disease.
* **Option C:** This option is incorrect because, although it might relate to some genetic or molecular aspects, it does not correctly describe the specific defect in sickle cell disease.
## Clinical Pearl / High-Yield Fact
A key clinical pearl is that sickle cell disease patients are at risk of ** vaso-occlusive crises**, which can be triggered by dehydration, infection, or cold. These crises can lead to significant morbidity, including acute chest syndrome, stroke, and splenic sequestration.
## Correct Answer Line
**Correct Answer: D. **